Stabilisation Notice

RNS Number:1438J
Lehman Brothers Intl (Europe)
04 December 2007



Not for release or distribution, directly or indirectly, in or into the United
States or any jurisdiction in which such release or distribution would be
unlawful.

                          GlaxoSmithKline Capital plc
                              Stabilisation Notice


Lehman Brothers International (Europe) (contact: Andre Portelli / Kevin White ;
telephone: 020 7103 8398 / 020 7103 7933) hereby gives notice that the
Stabilising Managers named below may stabilise the offer of the following
securities in accordance with Commission Regulation (EC) No. 2273/2003 of 22
December 2003 implementing the Market Abuse Directive (2003/6/EC).


The securities:

Issuer: GlaxoSmithKline Capital plc
Description:
Euro 2,250,000,000 Fixed Rate Notes due 13 December 2012 &
Euro 1,250,000,000 Fixed Rate Notes due 13 December 2017
Offer price:
2012 maturity : +85 basis points over the 5 year mid-swap rate
2017 maturity : +115 basis points over the 10 year mid-swap rate

Stabilisation:

Stabilising Managers:
Credit Suisse Securities (Europe) Limited
Deutsche Bank AG, London Branch
Lehman Brothers International (Europe)
Stabilisation period expected to start on: 4 December 2007
Stabilisation period expected to end no later than: 11 January 2008 (30 days
after the proposed issue date of the securities)
Maximum size of over-allotment facility: 5% of the aggregate nominal amount
stated above


Offering Circular:

The Euro Medium Term Note Programme Offering Circular dated 9 March 2007 and the
Securities Note dated 4 December 2007 relating to these securities are
available. The Securities Note should be read in conjunction with the
Registration Document dated 9 March 2007 and certain parts of the Offering
Circular dated 9 March 2007 which are incorporated by reference in the
Securities Note (together the "Securities Note").

In connection with the offer of the above securities, the Stabilising Manager
may over-allot the securities or effect transactions with a view to supporting
the market price of the securities at a level higher than that which might
otherwise prevail.  However, there is no assurance that the Stabilising Manager
will take any stabilisation action and any stabilisation action, if begun, may
be ended at any time.

This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or dispose
of any securities of the Issuer in any jurisdiction.

To the extent that the offer of the securities is made in any EEA Member State
that has implemented Directive 2003/71/EC (together with any applicable
implementing measures in any Member State, the "Prospectus Directive") before
the date of publication of a prospectus in relation to the securities which has
been approved by the competent authority in that Member State in accordance with
the Prospectus Directive (or, where appropriate, published in another Member
State and notified to the competent authority in that Member State in accordance
with the Prospectus Directive), the offer is only addressed to qualified
investors in that Member State within the meaning of the Prospectus Directive or
has been or will be made otherwise in circumstances that do not require the
Issuer to publish a prospectus pursuant to the Prospectus Directive.

This announcement is not an offer of securities for sale in the United States.
The securities have not been, and will not be, registered under the United
States Securities Act of 1933 and may not be offered or sold in the United
States absent registration or an exemption from registration.  There will be no
public offer of securities in the United States.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

STATIBITMMBMBPR
Glaxosmsc 5.25% (LSE:AG99)
過去株価チャート
から 12 2024 まで 1 2025